G1 Therapeutics, Inc. Insider Trading for November 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in G1 Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in G1 Therapeutics, Inc. for November 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | PHILLIPS BARCLAY A | SVP & Chief Financi ... | Option Exercise | M | 19.46 | 5,000 | 97,300 | 95,000 | |
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | PHILLIPS BARCLAY A | SVP & Chief Financi ... | Sell | S | 39.92 | 5,000 | 199,591 | 0 | 5 K to 0 (-100.00 %) |
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | PHILLIPS BARCLAY A | SVP & Chief Financi ... | Buy | M | 19.46 | 5,000 | 97,300 | 5,000 | 0 to 5 K |
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Option Exercise | M | 3.72 | 5,000 | 18,600 | 119,433 | |
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 40.59 | 15 | 609 | 19,000 | 19 K to 19 K (-0.08 %) |
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Sell | S | 39.84 | 4,985 | 198,602 | 19,015 | 24 K to 19 K (-20.77 %) |
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | Velleca Mark A. | President and CEO | Buy | M | 3.72 | 5,000 | 18,600 | 24,000 | 19 K to 24 K (+26.32 %) |
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Option Exercise | M | 4.17 | 3,776 | 15,746 | 69,295 | |
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Sell | S | 40.31 | 247 | 9,958 | 14,700 | 14.9 K to 14.7 K (-1.65 %) |
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Sell | S | 39.71 | 3,529 | 140,147 | 14,947 | 18.5 K to 14.9 K (-19.10 %) |
| Nov 16 2018 | GTHX | G1 Therapeutics, I ... | Malik Rajesh | Ch. Medical Officer ... | Buy | M | 4.17 | 3,776 | 15,746 | 18,476 | 14.7 K to 18.5 K (+25.69 %) |
| Nov 07 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Option Exercise | M | 0.39 | 10,000 | 3,900 | 607 | ||
| Nov 07 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Sell | S | 41.53 | 10,000 | 415,347 | 0 | 10 K to 0 (-100.00 %) | |
| Nov 07 2018 | GTHX | G1 Therapeutics, I ... | RUDNICK SETH | Buy | M | 0.39 | 10,000 | 3,900 | 10,000 | 0 to 10 K | |
| Nov 07 2018 | GTHX | G1 Therapeutics, I ... | MURDOCK TERRY L | SVP of Development ... | Option Exercise | M | 13.51 | 3,519 | 47,542 | 85,924 | |
| Nov 07 2018 | GTHX | G1 Therapeutics, I ... | MURDOCK TERRY L | SVP of Development ... | Sell | S | 41.53 | 3,519 | 146,129 | 0 | 3.5 K to 0 (-100.00 %) |
| Nov 07 2018 | GTHX | G1 Therapeutics, I ... | MURDOCK TERRY L | SVP of Development ... | Buy | M | 13.51 | 3,519 | 47,542 | 3,519 | 0 to 3.5 K |
| Nov 07 2018 | GTHX | G1 Therapeutics, I ... | Moses Jennifer K. | VP of Finance & Adm ... | Option Exercise | M | 0.39 | 750 | 293 | 2,416 | |
| Nov 07 2018 | GTHX | G1 Therapeutics, I ... | Moses Jennifer K. | VP of Finance & Adm ... | Sell | S | 41.38 | 750 | 31,035 | 2,000 | 2.8 K to 2 K (-27.27 %) |
| Nov 07 2018 | GTHX | G1 Therapeutics, I ... | Moses Jennifer K. | VP of Finance & Adm ... | Buy | M | 0.39 | 750 | 293 | 2,750 | 2 K to 2.8 K (+37.50 %) |